BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 27308652)

  • 1. Contrast-Enhanced Ultrasound: a Simple and Effective Tool in Defining a Rapid Diagnostic Work-up for Small Nodules Detected in Cirrhotic Patients during Surveillance.
    Giorgio A; Montesarchio L; Gatti P; Amendola F; Matteucci P; Santoro B; Merola MG; Merola F; Coppola C; Giorgio V
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):205-11. PubMed ID: 27308652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.
    Forner A; Vilana R; Bianchi L; Rodríguez-Lope C; Reig M; García-Criado MÁ; Rimola J; Solé M; Ayuso C; Bru C; Bruix J
    J Hepatol; 2015 Jan; 62(1):150-5. PubMed ID: 25173969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
    Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
    Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of contrast-enhanced intraoperative ultrasound for cirrhotic patients with hepatocellular carcinoma: a report of 20 cases.
    Lu Q; Luo Y; Yuan CX; Zeng Y; Wu H; Lei Z; Zhong Y; Fan YT; Wang HH; Luo Y
    World J Gastroenterol; 2008 Jul; 14(25):4005-10. PubMed ID: 18609684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
    Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
    Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
    Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
    Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging.
    Giorgio A; De Stefano G; Coppola C; Ferraioli G; Esposito V; Di Sarno A; Giorgio V; De Stefano M; Sangiovanni V; Liorre G; Del Viscovo L
    Anticancer Res; 2007; 27(6C):4263-9. PubMed ID: 18214030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver.
    Pompili M; Riccardi L; Semeraro S; Orefice R; Elia F; Barbaro B; Covino M; Grieco A; Gasbarrini G; Rapaccini GL
    Dig Liver Dis; 2008 Mar; 40(3):206-15. PubMed ID: 18054850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound.
    Giorgio A; Calisti G; di Sarno A; Farella N; de Stefano G; Scognamiglio U; Giorgio V
    Anticancer Res; 2011 Nov; 31(11):3977-82. PubMed ID: 22110230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.
    Iavarone M; Viganò M; Piazza N; Occhipinti V; Sangiovanni A; Maggioni M; D'Ambrosio G; Forzenigo LV; Motta F; Lampertico P; Rumi MG; Colombo M
    Ann Hepatol; 2019; 18(2):318-324. PubMed ID: 31036496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound.
    Xu HX; Lu MD; Liu LN; Zhang YF; Guo LH; Xu JM; Liu C
    Br J Radiol; 2012 Oct; 85(1018):1376-84. PubMed ID: 22553290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound.
    Kim TK; Lee KH; Khalili K; Jang HJ
    Abdom Imaging; 2011 Jun; 36(3):244-63. PubMed ID: 21253723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
    Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
    Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEUS: An essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma.
    Jang HJ; Kim TK; Burns PN; Wilson SR
    Eur J Radiol; 2015 Sep; 84(9):1623-35. PubMed ID: 26092406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma.
    Martie A; Sporea I; Popescu A; Sirli R; Dănilă M; Serban C; Ardelean M; Bota S; Sendroiu M; Chisevescu D
    Med Ultrason; 2011 Jun; 13(2):108-13. PubMed ID: 21655536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.
    Zhang XY; Luo Y; Wen TF; Jiang L; Li C; Zhong XF; Zhang JY; Ling WW; Yan LN; Zeng Y; Wu H
    World J Gastroenterol; 2014 Sep; 20(35):12628-36. PubMed ID: 25253968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.